$WVE crashed its most on record on March 26.
Stock dropped 50% in a single session.
Wave Life Sciences is a clinical stage biotech company developing RNA-based medicines, most notably an obesity drug (WVE-007) that showed fat loss comparable to GLP-1s like Ozempic but with once or twice a year dosing.
Why did $WVE crash?
Its obesity drug WVE-007 at a higher dosage showed just 0.9% weight loss over placebo. FDA wants to see 5% at least.
RA Capital started buying $54 million on that exact same day. Four consecutive days accumulating. $30M, then $2.2M, then $16M, then $6.3M.
RA Capital is one of the most respected specialist healthcare funds in the industry. They read clinical data for a living.
So what do they know that the herd doesn't?
The lower 240mg dose actually worked. 14% visceral fat reduction at six months, with patients gaining lean muscle. That's a profile no GLP-1 can match. Ozempic melts fat but it also melts muscle. WVE-007 appears to do one without the other.
The higher dose "miss" may be noise, not signal.
Oppenheimer's analyst argues the 400mg data was thrown off by patient baseline variability, not a failure of the drug itself. And the trial enrolled people with BMIs around 32. That's barely obese.
The Phase 2a starting next quarter recruits patients with BMIs of 35 to 50 with actual obesity-related conditions. More fat to lose, better numbers to show.
The mechanism is genuinely different from everything else in the obesity space. WVE-007 silences a gene called INHBE linked to fat accumulation.
One injection, once or twice a year. Not weekly shots. Not appetite suppression. A completely different pathway.
Could it fail in Phase 2?
Absolutely. It's early-stage biotech and this is Phase 1 data in a tiny cohort. But every analyst covering WVE still rates it a Buy. Consensus price target is above $28. The stock is around $7.28
The market saw a bad headline and ran. A specialist fund with deep domain expertise saw the same data and wrote a nine-figure check in the opposite direction.
Someone is very wrong here.
RA Capital just put $54.6 million on who.